Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Shock. 2014 Nov;42(5):424–431. doi: 10.1097/SHK.0000000000000231

Figure 1.

Figure 1

Erythropoietin (rhEPO) is protective against liver ischemia reperfusion (IR) injury. A, B. Serum aspartate aminotransferase (AST, A) and alanine aminotransferase (ALT, B) levels were significantly decreased 4 hours after reperfusion when rhEPO was given at the time of reperfusion. ** = p<0.01, rhEPO treated vs. untreated. C. Hematoxylin & eosin staining of livers 4 and 24 hours after IR with or without rhEPO demonstrates a significant decrease in necrosis in rhEPO-treated livers. Sham treated and untreated sections are shown as controls; representative sections are at 10×.